Small molecules, such as oligopeptides functioning as ligands of neurotrophin receptors, can modulate neurotrophin signaling and are able to ameliorate pathological features in neurodegenerative disease models [70,77,78,79]. This evidence concerns the gene BDNF and neurodegenerative disease.